Navigation Links
Parkway Clinical Laboratories Expands Management Team to Support a National Growth Strategy Centered on Oral Fluid Drug Screening
Date:1/7/2008

BENSALEM, Pa., Jan. 7 /PRNewswire/ -- Parkway Clinical Laboratories (http://www.parkwayclinical.com), a national, full-service, CLIA-certified clinical reference laboratory located in Bensalem, Pa., has expanded its management team by naming Mats Sanden, M.D., as medical director, Masood Haider, Ph.D., as vice president of Operations, Carolyn Bonner as director of Business Development and John Carson as director of Sales.

"We begin the New Year with a resolve to rapidly grow our various service offerings. I am particularly excited about our Intercept oral fluid employee substance abuse testing service and comfortably see us establishing a national footprint in this area in a very short period of time. We are assembling a very competent team that is not only diverse but a pleasure to work with," said Dr. Raza Bokhari, chairman and CEO, Parkway Clinical Laboratories.

Drs. Sanden and Haider are devoted to operational excellence and securing highest accreditation and certifications.

Carolyn Bonner is leading the national growth plan for the oral fluid employee drug screening service using the Orasure Intercept collection device and testing methodology, targeting local, regional, national and international corporations.

John Carson is focused on increasing a concentrated regional presence as a full service clinical reference laboratory for medical practitioners and veterinarians as well as strengthening existing relations in the mental and behavioral health market segment.

About Parkway Clinical Laboratories

Parkway Clinical Laboratories (PCL) is an emerging national CLIA-certified clinical reference laboratory performing routine and esoteric diagnostic testing with a focus on oral fluid substance of abuse screening in workplace environments (settings or arenas). Conveniently located in Bensalem, Pa., our primary facility is situated in the northeast subu
'/>"/>

SOURCE Parkway Clinical Laboratories
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Philadelphia Insurance Companies to Sponsor the 2007 Parkway Run/Walk
2. Ardea Biosciences Lead NNRTI for HIV, RDEA806, to Enter Phase 2a Proof-of- Concept Clinical Trial
3. ADA Issues New Clinical Practice Recommendations
4. Immtech Announces Pafuramidine (DB289) Program on Clinical Hold
5. Menopausal Women May Have an Increased Asthma Risk, From The Journal of Allergy and Clinical Immunology
6. New Book Looks at Clinical Research from the Patients Point of View
7. Xeloda(R), Taxotere(R) and Herceptin(R) Combination Study Suggests Clinical Benefit in Invasive Breast Cancer with Shortened Treatment Cycle
8. QRxPharma Initiates Second Phase III Clinical Trial for its Dual Opioid Pain Therapy
9. Advanced Clinical Research Services Enhances Biostatistics Offering
10. Sunesis Pharmaceuticals SNS-595 Shows Clinical Activity in Patients With Relapsed or Refractory Acute Leukemias; Data Presented in Oral Session at 49th Annual Meeting of the American Society of Hematology
11. Pharmion and MethylGene Present Favorable Clinical Data From Combination MGCD0103/Vidaza(R) Study in Myelodysplastic Syndromes and Acute Myelogenous Leukemia at The 49th American Society of Hematology (ASH) Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...purpose bilingual coloring books designed for chil...s community to educate - inform parents and childr...es to Dinosuars to ABC,S and a host of other topic...EB) November 27, 2009 -- Today’s children ha...m busy any hour of the day, but one of the oldest ...
(Date:11/26/2009)...RNewswire/ -- With cold and flu season upon us, it...es to control the spread of infections and avoid i... keep ourselves healthy, but to avoid transmitting...MS, CIC (certified in infection-control), nursing ...alth at Hospital for Special Surgery (HSS) in Manh...
(Date:11/26/2009)...etrathiomolybdate (TM) has been shown in studies t... a disease caused by an overload of copper, and ce... little, however, is known about how the drug work...orthwestern University researchers now has provide...ure of TM bound to copper-loaded metallochaperones...
(Date:11/26/2009)...e letters from the North Pole, Textsanta.net lets ...m Santa , North Pole, AK ...ficiencies at the North Pole Santa Claus has added... the globe informed of his Christmas progress at t... department have identified a large and growing pe...
(Date:11/26/2009)... Communications announces a highly effective and u... struggling to make an economic recovery. , ...u fears is the type of challenge that could send a...ng to Dr. David Benton, business growth expert and...em – The Rfactor Intensive . “Fear ...
Breaking Medicine News(10 mins):Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Pharmacist Injects Cure for Ailing Businesses 2
...nology and sensor standardization across it...ngs, IRVINE, Calif., July 31 Masimo, the invento...and-Low-Perfusion Pulse,Oximetry, announced that A...s and more than 100 clinics performed an,independe...
...Portland and Seattle that improve health ... July 31 The Regence Foundation today,announced t...rking to,improve health care quality. Launched in ...ositive transformation of,the health care system.,...
...IDS and health systems,expert Ann Lion Coleman wil...ystems 20/20 project in August 2008. Health System...gship project working to strengthen health,systems... health services., Lion Coleman comes to Abt Asso...
...RNewswire/ -- Chindex International,Inc. (Nasdaq: ...f Western,healthcare products and services in the ...t intends to release its fiscal 2009 first quarter...ancial results., To participate in the conference...
...mission will dialogue with leaders at,the Conferen...in response,to the HIV/AIDS pandemic, NEW YORK, J...ond most affected community, it is estimated that ...% of,the population in the U.S. and its territorie...
...blacks, Hispanics, and males not getting message, ... News) -- In the past 17 years, there has been an...U.S. teens, a new government study shows. , The r...orted Thursday. , However, the rates of risky sexu...
Other Medicine News:Health News:Aurora Health Care Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 2Health News:Aurora Health Care Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 3Health News:Aurora Health Care Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 4Health News:Aurora Health Care Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 5Health News:Regence Foundation Announces Three Grants Totaling $195,000 2Health News:Ann Lion Coleman Joins Abt Associates to Direct USAID Health Systems 20/20 Project 2Health News:Chindex International to Report Fiscal 2009 First Quarter Financial Results 2Health News:Chindex International to Report Fiscal 2009 First Quarter Financial Results 3Health News:The Latino Commission on AIDS Releases Report on the State of HIV/AIDS in Latino/Hispanic Communities in the United States on the Eve of the International AIDS Conference in Mexico City 2Health News:Risky Sexual Behaviors Decreasing Among U.S. Teens 2
(Date:11/25/2009)..., BEDFORD, Mass., Nov. 25 /PRNewswire-FirstCall/ -... HOLX ), a leading developer, manufacturer and sup...ems and surgical products dedicated to serving the...eting of the Radiological Society of North America... through December 3, 2009 to highlight our new Sec...
(Date:11/25/2009)...IDGEWATER, N.J., Nov. 25 The FDA g...travirine) tablets, a non-nucleoside reverse trans...NNRTI specifically indicated for use in treatment-...failure with HIV-1 strains resistant to an NNRTI a...onal approval is based on 48-week data from two Ph...
(Date:11/25/2009)..., HARBIN, China, Nov. 25 /PRNewswire-Asia-Fi...y One Medical" or "the Company") (Nasdaq: CSKI ),... developing and producing,over-the-counter drugs i...nounced that the Company recently passed the Chine...tical and Biological Products ("ICPBP") examinatio...
Breaking Medicine Technology:New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Fossil teeth of browsing horse found in Panama Canal earthworks 8744 1Fossil teeth of browsing horse found in Panama Canal earthworks 8744 2EHE International Supports the National Headache Foundation 48180 1EHE International Supports the National Headache Foundation 48180 2Joint Statement on Atypical Antipsychotic Use in Children 48176 1Joint Statement on Atypical Antipsychotic Use in Children 48176 2Joint Statement on Atypical Antipsychotic Use in Children 48176 3
...pril 29 Alexza,Pharmaceuticals, Inc. (Nasdaq: AL... 1 clinical trial of AZ-007 (Staccato(R) zaleplon)...developed for the treatment of insomnia,patients w...nts who awake,in the middle of the night and have ...th product candidate using our single-dose Staccat...
...il 29 At a late breaking,presentation made on Apr...Atherosclerosis Society held in Istanbul, the inve...ngs of a one year trial aiming at,further studying...HDL and,on a comprehensive set of cardiometabolic ...mputed tomography was conducted to test, for the f...
Other Medicine Technology:Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon) 2Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon) 3Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon) 4Imaging Results From the ADAGIO-LIPIDS Reveal That Effects of Rimonabant on Cardiometabolic Risk Profile Include Loss of Visceral Fat and Mobilization of Liver Fat 2Imaging Results From the ADAGIO-LIPIDS Reveal That Effects of Rimonabant on Cardiometabolic Risk Profile Include Loss of Visceral Fat and Mobilization of Liver Fat 3Imaging Results From the ADAGIO-LIPIDS Reveal That Effects of Rimonabant on Cardiometabolic Risk Profile Include Loss of Visceral Fat and Mobilization of Liver Fat 4
200 L Pipette Tip (RNase, DNase and pyrogen free)
MBP XLPFor Hard-to-Reach Places
MBP 300E Multi-Channel
Luteinizing hormone (LH) ELISA
Medicine Products: